A recent study by the Cancer Proteolytic Pathways Research Group addresses a key reason why cancer remains difficult to treat: many tumours establish a profoundly immunosuppressive microenvironment that compromises anti-tumour immunity. Among the most promising effector populations are natural killer (NK) cells, which can efficiently recognize and eliminate cancer stem cells—a tumour subpopulation often resistant […]
Read More
Targeting cystatin F activation enhances NK cell cytotoxicity in glioblastoma models
- 4.February, 2026
- Comments off